King's College Hospital NHS Foundation Trust

Running trials

• Recruiting

  REAL-MS: Observational Database Study of AHSCT and MS Therapies

  NCT07899502· Imperial College London· Source

• Not yet recruiting

  Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool

  NCT07704294· King's College London· Source

• Recruiting

  DElirium and LIGHT: Exploring Modifiable Risk Factors of Delirium - a Pilot Study

  NCT07791472· King's College Hospital NHS Trust· Source

• Recruiting

  Feasibility of Good Boost+ for Adults Awaiting Total Knee Replacement

  NCT07532785· King's College Hospital NHS Trust· Source

• Active, not recruiting

  The REFLECT Study- Flares in axSpA

  NCT07688174· Royal United Hospitals Bath NHS Foundation Trust· Source

• Recruiting

  Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

  NCT07585890· University Medical Center Groningen· Source

• Recruiting

  A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07284758· Phase 2· C4 Therapeutics, Inc.· Source

• Not yet recruiting

  Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial

  NCT07295834· Phase 2· Imperial College London· Source

• Recruiting

  Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

  NCT07096778· Phase 2· CellCentric Ltd.· Source

• Recruiting

  Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

  NCT07033598· Phase 2· Theradex· Source

• Recruiting

  Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  NCT06659445· Phase 2· ONL Therapeutics· Source

• Recruiting

  A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  NCT07175285· Bristol-Myers Squibb· Source

• Recruiting

  Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

  NCT05691244· Phase 3· Pharmazz, Inc.· Source

• Recruiting

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· Phase 2/3· Exelixis· Source

• Recruiting

  Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

  NCT06464926· Enterra Medical, Inc.· Source

• Active, not recruiting

  A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

  NCT06821542· Phase 3· Incyte Corporation· Source

• Recruiting

  Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma

  NCT06762769· Phase 2· University College, London· Source

• Recruiting

  A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

  NCT07363044· Alimentiv Inc.· Source

• Recruiting

  Closed-loop in Adults With Type 2 Diabetes

  NCT06579404· University of Cambridge· Source

• Active, not recruiting

  Phase 2b Open-Label Repeat Kidney Biopsy Study

  NCT06740526· Phase 2· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Active, not recruiting

  A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

  NCT06447168· Ipsen· Source

• Active, not recruiting

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· Phase 3· Cerevance· Source

• Recruiting

  Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery

  NCT04103372· Imperial College London· Source

• Recruiting

  Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)

  NCT06326957· King's College Hospital NHS Trust· Source

• Recruiting

  Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)

  NCT05996120· University of Leicester· Source

• Recruiting

  Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial

  NCT05405868· Phase 3· University College, London· Source

• Recruiting

  Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

  NCT06556446· Insel Gruppe AG, University Hospital Bern· Source

• Recruiting

  CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis

  NCT06223893· University College, London· Source

• Active, not recruiting

  Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

  NCT05890729· Phase 1/2· Xentria, Inc.· Source

• Recruiting

  Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

  NCT05848765· Phase 2· University of Birmingham· Source

• Active, not recruiting

  A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

  NCT06015841· Phase 2· AC Immune SA· Source

• Recruiting

  A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

  NCT06461208· Phase 3· King's College London· Source

• Recruiting

  DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

  NCT05389774· Nottingham University Hospitals NHS Trust· Source

• Recruiting

  A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  NCT05431088· Phase 2/3· Pfizer· Source

• Active, not recruiting

  Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

  NCT05371093· Phase 3· Kite, A Gilead Company· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

  NCT05500222· Phase 3· Madrigal Pharmaceuticals, Inc.· Source

• Recruiting

  Adult SMA Research and Clinical Hub

  NCT06978985· Newcastle-upon-Tyne Hospitals NHS Trust· Source

• Recruiting

  The South London Stroke Register: Improving the Lives of Stroke Survivors With Data

  NCT05298436· Guy's and St Thomas' NHS Foundation Trust· Source

• Active, not recruiting

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

  NCT05031780· Phase 2/3· Agios Pharmaceuticals, Inc.· Source

• Active, not recruiting

  COVID-19 Antibody Responses In Cystic Fibrosis

  NCT04863573· Queen's University, Belfast· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

  NCT05050136· Phase 2· Mirum Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

  NCT04849728· Phase 3· Inventiva Pharma· Source

• Active, not recruiting

  Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

  NCT04624230· Phase 3· Pfizer· Source

• Recruiting

  Clinical Outcome Modelling of Rapid Dynamics in Acute Stroke

  NCT04641286· King's College Hospital NHS Trust· Source

• Recruiting

  Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

  NCT04663750· Phase 3· King's College Hospital NHS Trust· Source

• Active, not recruiting

  A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19

  NCT02735083· Phase 1· Institut de Recherches Internationales Servier· Source

• Recruiting

  A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  NCT04710576· Phase 2· Syndax Pharmaceuticals· Source

• Recruiting

  Statins for Venous Event Reduction in Patients With Venous Thromboembolism

  NCT04319627· Phase 3· Ottawa Hospital Research Institute· Source

• Recruiting

  Tessa Jowell BRAIN MATRIX - Platform Study

  NCT04274283· University of Birmingham· Source

Showing 50 of 62.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke4 recruiting
• Liver cirrhosis3 recruiting
• Multiple myeloma3 recruiting
• Childhood cancers2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Crohn's disease2 recruiting
• Lung cancer2 recruiting
• Macular degeneration2 recruiting
• Multiple sclerosis2 recruiting
• Sarcoidosis2 recruiting
• Acute myeloid leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Asthma1 recruiting
• Bronchiectasis1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• COPD1 recruiting
• Coronary artery disease1 recruiting
• Deep vein thrombosis and pulmonary embolism1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Follicular lymphoma1 recruiting
• Giant cell arteritis1 recruiting
• Glaucoma1 recruiting
• Lupus (SLE)1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroendocrine tumours1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Optic neuritis1 recruiting
• Osteoarthritis1 recruiting
• Pancreatic cancer1 recruiting
• Polymyalgia rheumatica1 recruiting
• Sickle cell disease1 recruiting
• Spinal muscular atrophy1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  FibroScan-Reproducibility and Repeatability Study

  NCT06877026· Echosens· Source

• Completed

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· Phase 2· Bayer· Source

• Completed

  Trial of Mirtazapine for Depression in IBD

  NCT06309472· Phase 2· King's College London· Source

• Completed

  An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

  NCT06169397· Phase 2· Xentria, Inc.· Source

• Completed

  Children's Adaptive Deep Brain Stimulation for Epilepsy Trial (CADET): Pilot

  NCT05437393· University College, London· Source

• Completed

  A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05767021· Phase 3· Eli Lilly and Company· Source

• Completed

  GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

  NCT05470751· ConvaTec Inc.· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Bayer· Source

• Completed

  Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

  NCT05525520· Phase 2· Escient Pharmaceuticals, Inc· Source

• Completed

  STEM-Parkinson's Disease

  NCT04797611· Scion NeuroStim· Source

• Terminated

  Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

  NCT05275439· Phase 1· Shattuck Labs, Inc.· Source

• Completed

  An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheumatoid Arthritis

  NCT05170646· AbbVie· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· Phase 2· Calliditas Therapeutics Suisse SA· Source

• Completed

  Bacterial Lysate In Preventing Asthma

  NCT05064631· Phase 2· Queen Mary University of London· Source

• Completed

  A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

  NCT05014412· Phase 2· Pfizer· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Bayer· Source

• Completed

  Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

  NCT04891770· Phase 2· Gilead Sciences· Source

• Completed

  Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

  NCT04722991· Phase 2· Bayer· Source

• Completed

  A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

  NCT04686136· Phase 3· AbbVie· Source

• Completed

  PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

  NCT04870333· Phase 2/3· Cambridge University Hospitals NHS Foundation Trust· Source

• Terminated

  Hydroxychloroquine in ANCA Vasculitis Evaluation

  NCT04316494· Phase 4· Guy's and St Thomas' NHS Foundation Trust· Source

• Completed

  Psychological Impact of COVID-19 on Intensive Care Survivors

  NCT05092529· Royal Liverpool University Hospital· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Oxurion· Source

• Terminated

  Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

  NCT04365868· Phase 2/3· Galectin Therapeutics Inc.· Source

• Completed

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Concept Medical Inc.· Source

• Recruiting

  A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  NCT03394365· Phase 3· Pierre Fabre Medicament· Source

• Completed

  A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

  NCT02942290· Phase 1· AbbVie· Source

• Completed

  Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

  NCT02467270· Phase 2· Takeda· Source

• Completed

  Stereotactic Radiotherapy for Wet AMD (STAR)

  NCT02243878· Phase 3· King's College Hospital NHS Trust· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Acute lymphoblastic leukaemia12 works · 0 trials
• Ankylosing spondylitis10 works · 1 trial
• Gastroparesis6 works · 0 trials
• Huntington's disease6 works · 0 trials
• Primary biliary cholangitis4 works · 5 trials
• Aplastic anaemia4 works · 0 trials
• Giant cell arteritis4 works · 1 trial